Wilson disease mechanisms manipulate ATP7B activity

Copper is an essential cofactor for enzymes involved in diverse processes including mitochondrial respiration and the metabolism of neurotransmitters, collagen and melanin. However, its redox activity requires tight homeostatic control. The P-type ATPases ATP7A and ATP7B help deliver copper to cuproenzymes, and ATP7B mediates the excretion of excess copper into bile. Pathogenic ATP7B variants cause Wilson disease (WD), leading to copper accumulation in organs including the liver, kidney, and brain, and to disruption of copper-dependent processes. Current treatments primarily reduce systemic copper levels, while emerging gene therapies aim to restore ATP7B function. A complementary therapeutic strategy would be to rescue dysfunctional ATP7B using pharmacological chaperones, but their development is limited by an insufficient understanding of how WD variants perturb ATP7B structure and function. Here, we present a cryo-EM structure of human ATP7B reconstituted in lipid nanodiscs together with coarse-grained molecular dynamics simulations, as well as mutagenesis, functional and sequence analyses. We identify a salt bridge (E754-R969), crucial for the transition between inward- and outward-facing conformations, which is abolished by the R969Q disease variant. Additionally, we find a conserved stabilizing cholesterol-binding site severely disrupted by the WD variant W939C. Furthermore, we present new insights into the dynamics of metal binding domains 5 and 6 hinting at a copper relay mechanism in ATP7B. Together, these findings reveal lipid- and domain-mediated mechanisms of ATP7B regulation and explain how specific WD variants disrupt them, providing a structural framework for mutation-directed therapeutic strategies, including pharmacological chaperones.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.766959
Primary Topic
Trace Elements in Health
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Wilson disease mechanisms manipulate ATP7B activity

Anna L. Duncan, Charlott Stock, Poul Nissen, Thibaud Dieudonné et al.
bioRxiv (Cold Spring Harbor Laboratory)
Trace Elements in Health
preprint

Wilson disease mechanisms manipulate ATP7B activity

Anna L. Duncan, Charlott Stock, Poul Nissen, Thibaud Dieudonné, Orsolya Mózner, Tomáš Heger, Ida Marie Skøtt
preprint en

Abstract

Copper is an essential cofactor for enzymes involved in diverse processes including mitochondrial respiration and the metabolism of neurotransmitters, collagen and melanin. However, its redox activity requires tight homeostatic control. The P-type ATPases ATP7A and ATP7B help deliver copper to cuproenzymes, and ATP7B mediates the excretion of excess copper into bile. Pathogenic ATP7B variants cause Wilson disease (WD), leading to copper accumulation in organs including the liver, kidney, and brain, and to disruption of copper-dependent processes. Current treatments primarily reduce systemic copper levels, while emerging gene therapies aim to restore ATP7B function. A complementary therapeutic strategy would be to rescue dysfunctional ATP7B using pharmacological chaperones, but their development is limited by an insufficient understanding of how WD variants perturb ATP7B structure and function. Here, we present a cryo-EM structure of human ATP7B reconstituted in lipid nanodiscs together with coarse-grained molecular dynamics simulations, as well as mutagenesis, functional and sequence analyses. We identify a salt bridge (E754-R969), crucial for the transition between inward- and outward-facing conformations, which is abolished by the R969Q disease variant. Additionally, we find a conserved stabilizing cholesterol-binding site severely disrupted by the WD variant W939C. Furthermore, we present new insights into the dynamics of metal binding domains 5 and 6 hinting at a copper relay mechanism in ATP7B. Together, these findings reveal lipid- and domain-mediated mechanisms of ATP7B regulation and explain how specific WD variants disrupt them, providing a structural framework for mutation-directed therapeutic strategies, including pharmacological chaperones.

bioRxiv (Cold Spring Harbor Laboratory)
Centre National de la Recherche Scientifique (FR), Aarhus University (DK), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), Institut de Biologie Intégrative de la Cellule (FR), CEA Paris-Saclay (FR)
Carlsbergfondet, Lundbeckfonden, HORIZON EUROPE Framework Programme
Good health and well-being
Trace Elements in Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon